Skip to content

GRACE - Genetic Insights Into Early pRegnancy Loss Using Cell-free fEtal DNA

GRACE - Genetic Insights Into Early pRegnancy Loss: A Prospective Study Using Cell-free fEtal DNA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07639333
Acronym
GRACE
Enrollment
100
Registered
2026-06-10
Start date
2026-09-01
Completion date
2029-01-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Miscarriage in First Trimester, Prenatal Genetic Diagnosis

Keywords

early miscarriage, miscarriage, prenatal diagnosis, prenatal test, cell free fetal DNA, chromosomal abnomarlities

Brief summary

The aim of this study is to assess the impact of non-invasive prenatal testing right after an early isolated miscarriage on mental health and on the patient's subsequent care in the year following the miscarriage

Detailed description

A blood sample will be added to primary care at the time of diagnosis of early miscarriage to realise non-invasive prenatal testing (NIPT). NIPT will be done on cell-free fetal DNA present in woman's blood to detect potential chromosomal abnormalities. At the 8-week consultation, the results will be shared with the patient if she so wishes. During this appointment, two questionnaires designed to assess her psychological state in relation to the miscarriage (HAD and PGS) will be completed. Depending on the patient's medical history and the results of the NIPT, a tailored care plan may be proposed. At the one-year follow-up appointment, the same questionnaires will be completed and a review will be carried out of the care proposed and provided, as well as the couple's future reproductive plans.

Interventions

GENETICNon invasive prenatal test

cell free fetal DNA analysis

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

Patient can refuse to know the result of NIPT

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 43 Years
Healthy volunteers
No

Inclusion criteria

* A stopped pregnancy with an intrauterine pregnancy diagnosed by ultrasound (embryo larger than 7 mm corresponding to a gestational age of 6 weeks and 5 days. This is justified by the fact that fetal fragment (FF) detection is possible at 5 weeks of gestation, or 7 weeks and 5 days) * Expulsion of a pregnancy within the last 2 hours * Patient fluent in French * Enrolled in a social security program * Has received oral and written information about the protocol and has signed a consent form to participate in this research.

Exclusion criteria

* Diagnosis of an empty gestational sac, ectopic pregnancy, or unknown location * Ultrasound findings consistent with a molar pregnancy * Identified cause (preimplantation diagnosis, multiple uterine fibroids or a single fibroid \> 5 cm, uterine malformation affecting the uterine cavity, lupus, and antiphospholipid syndrome) * Inability to obtain a blood sample * Known current malignant tumor * Blood transfusions within the last 3 months * Cell therapy or immunotherapy within the last 3 months * Previous organ transplant

Design outcomes

Primary

MeasureTime frameDescription
Psychological distress score8 weeksHADS (Hospital Anxiety and Depression Scale) and PGS (Perinatal Grief Scale) scores. The impact of the NIPT results will be analyzed in relation to these scores, which will be combined into a composite score of psychological distress. HADS questionnaire : Each item is rated on a four-point scale, giving maximum scores of 21 for anxiety and depression. Scores of 11 or more on either subscale are considered to be a significant 'case' of psychological morbidity, while scores of 8-10 represents 'borderline' and 0-7 'normal' The PGS is a self-report questionnaire designed to assess the emotional and psychological impact of perinatal loss, including miscarriage, stillbirth, or neonatal death. The more the score is high, the more the grief is intense.

Secondary

MeasureTime frameDescription
Long term Psychological distress score12 monthsHADS (Hospital Anxiety and Depression Scale) and PGS (Perinatal Grief Scale) at 1 year. The impact of the DPNI results will be analyzed in relation to these scores, which will be combined into a composite score of psychological distress. HADS questionnaire : Each item is rated on a four-point scale, giving maximum scores of 21 for anxiety and depression. Scores of 11 or more on either subscale are considered to be a significant 'case' of psychological morbidity, while scores of 8-10 represents 'borderline' and 0-7 'normal' The PGS is a self-report questionnaire designed to assess the emotional and psychological impact of perinatal loss, including miscarriage, stillbirth, or neonatal death. The more the score is high, the more the grief is intense.
Rate of balanced chromosomal abnormalities in a parent8 weeksNumber of parents with a chromosomal rearrangement that explains the occurrence of an early miscarriage
Number of modified care pathways12 monthsNumber of modified care pathways based on the patient's etiology and the NIPT results during the year after miscarriages
Number of pregnancies12 monthsNumber of pregnancies and scalability during the year, according to care pathways and NIPT results

Countries

France

Contacts

CONTACTMarie-Laure Gervais
marie-laure.gervais@chu-rennes.fr299282555
STUDY_DIRECTORMarion Mercier, Md

Rennes University Hospital

STUDY_CHAIRVincent LAVOUE, Pr

Rennes University Hospital

STUDY_CHAIRSylvie JAILLARD

Rennes University Hospital

STUDY_CHAIRErika LAUNAY

Rennes University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026